PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

The two companies bring together cloud-based mobile technologies to improve the identification, screening and matching of patients to precision-based clinical oncology trialsRALEIGH, N.C. and COLUMBUS, Ohio, Sept. 18, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Friday, 18 September
Share |